                         SEQUENCE LISTING

<110>  Universit de Bretagne Occidentale
       Centre Hospitalier Rgional et Universitaire de Brest
       Institut national de la sant et de la recherche mdicale
 
<120>  PROTEASE-ACTIVATED RECEPTOR-2 INHIBITORS FOR THE TREATMENT OF 
       SENSORY NEUROPATHY INDUCED BY A MARINE NEUROTOXIC POISONING

<130>  B2986PC00

<150>  EP19305453
<151>  2019-04-05

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PAR-2 inhibitor pepducin


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-palmitoyl

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  amino

<400>  1

Arg Ser Ser Ala Met Asp Glu Asn Ser Glu Lys Lys Arg Lys Ser Ala 
1               5                   10                  15      


Ile Lys 
        


<210>  2
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PAR-2 inhibitor pepducin


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-palmitoyl

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  amino

<400>  2

Gly Asp Glu Asn Ser Glu Lys Lys Arg Lys Gln Ala Ile Lys 
1               5                   10                  


<210>  3
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PAR-2 inhibitor pepducin


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-palmitoyl

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  amino

<400>  3

Arg Met Leu Arg Ser Ser Ala Met Asp Glu Asn Ser Glu Lys Lys Arg 
1               5                   10                  15      


Lys Arg Ala Ile Lys 
            20      


<210>  4
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PAR2 inhibitor peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  amino

<400>  4

Phe Ser Leu Leu Arg Tyr 
1               5       


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PAR-2 inhibitor peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  amino

<400>  5

Leu Ser Ile Gly Arg Leu 
1               5       


<210>  6
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PAR-2 inhibitor peptide

<400>  6

Ser Leu Ala Gly Lys Val 
1               5       


<210>  7
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PAR-2 inhibitor peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  2-aminothiazol-4-yl

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  amino

<400>  7

Leu Ile Gly Arg Leu 
1               5   


<210>  8
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PAR-2 inhibitor peptide

<400>  8

Ser His Asp Phe Arg Asp His Ala 
1               5               


<210>  9
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PAR-2 inhibitor peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  acetyl

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  amino

<400>  9

Phe Phe Trp Phe His Val 
1               5       


<210>  10
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PAR-2 inhibitor peptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  amino

<400>  10

Arg Arg Phe Ser Leu Leu Arg Tyr 
1               5               


<210>  11
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PAR-2 inhibitor siRNA


<220>
<221>  RNA
<222>  (1)..(19)

<220>
<221>  DNA
<222>  (20)..(21)

<400>  11
uuaaacaggu uccacaucct a                                                 21


<210>  12
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PAR-2 cleavage peptide

<400>  12

Lys Val Asp Gly Thr Ser 
1               5       


